The Medical Supply Chain Resiliency Act aims to enhance the United States' capacity to secure a reliable supply of medical goods, particularly during public health emergencies. The legislation empowers the President to negotiate trade agreements that eliminate tariffs and other import barriers on medical supplies, thereby bolstering national security and public health. Central to the Act is the establishment of "trusted trade partner agreements" with other countries, designed to reduce trade barriers that impede the flow of medical goods.